Silvant Capital Management’s Organon & Co OGN Stock Holding History

Silvant Capital Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-441	Closed	-$9.13K	–	310
2024 Q2	$9.13K	Hold	441	–	–	﹤0.01%	306
2024 Q1	$8.29K	Hold	441	–	–	﹤0.01%	306
2023 Q4	$6.36K	Hold	441	–	–	﹤0.01%	300
2023 Q3	$7.66K	Hold	441	–	–	﹤0.01%	302
2023 Q2	$9.18K	Hold	441	–	–	﹤0.01%	303
2023 Q1	$10.4K	Hold	441	–	–	﹤0.01%	292
2022 Q4	$12.3K	Hold	441	–	–	﹤0.01%	292
2022 Q3	$10K	Hold	441	–	–	﹤0.01%	367
2022 Q2	$15K	Hold	441	–	–	﹤0.01%	321
2022 Q1	$15K	Hold	441	–	–	﹤0.01%	323
2021 Q4	$13K	Hold	441	–	–	﹤0.01%	323
2021 Q3	$14K	Sell	441 -3,000	-87%	-$96K	﹤0.01%	322
2021 Q2	$104K	Buy	+3,441	New	+$113K	0.02%	233

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Silvant Capital Management's OGN Position: Q3 2024 in Review

Silvant Capital Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 441 shares — an estimated $9.13K sold.

Silvant Capital Management first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $104K in Q2 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

Silvant Capital Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
Silvant Capital Management sold 441 Organon & Co shares in Q3 2024, an estimated $9.13K.
Silvant Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
Silvant Capital Management's Organon & Co position peaked at $104K in Q2 2021.
724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Silvant Capital Management's 13F filing for Q3 2024, filed 29 Oct 2024.